Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

IRWD Ironwood Pharmaceuticals Inc

3,69

-0,03 (-0,81%)

12 Déc 2024 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares sold to cover taxes from the vesting of stock awards granted by the Issuer.

Date of Notice

11/15/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Sravan Emany

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Ironwood Pharmaceuticals (NASDAQ:IRWD)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024

Plus de graphiques de la Bourse Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NASDAQ:IRWD)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024

Plus de graphiques de la Bourse Ironwood Pharmaceuticals

Actualités Ironwood Pharmaceuticals Inc

Form 8-K - Current report
Jeudi 5 Décembre 2024 ( il y a 6 jours) • Edgar (US Regulatory)

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
Mardi 26 Novembre 2024 ( il y a 2 semaines) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 20 Novembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 20 Novembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Vendredi 15 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Vendredi 15 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jeudi 14 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
Mercredi 13 Novembre 2024 ( il y a 4 semaines) • Business Wire

Form 8-K - Current report
Mardi 12 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jeudi 7 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 7 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
Jeudi 7 Novembre 2024 ( il y a 1 mois) • Business Wire

Plus d'articles sur Ironwood Pharmaceuticals Inc

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales